Tamoxifen Use and Risk of Uterine Diseases in Young Women With Breast Cancer
Among women of premenopausal age with breast cancer in Taiwan, tamoxifen as adjuvant hormone therapy was associated with increased risk of uterine diseases, including endometrial cancer. These findings highlight the importance of monitoring uterine diseases among tamoxifen users in this age range.
Authors
- Yi-Chun Yeh (ORCID: https://orcid.org/0009-0004-4307-4218)
- Cherry Chang
- Pei-Chun Chen
- Hsin-Ya Huang
Institutions
- Twitter (United States) (US)
- China Medical University (TW)
- National Confidential Enquiry into Patient Outcome and Death (GB)
- China Medical University Hospital (TW)
- Changhua Christian Hospital (TW)
Publication Details
- Journal
- Obstetrics and Gynecology
- Published
- 2026-03-05
- DOI
- https://doi.org/10.1097/aog.0000000000006238
- Primary Topic
- Estrogen and related hormone effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00